MCM
IBBQ icon

MAI Capital Management’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

MAI Capital Management’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-840
Closed -$24.4K – 3290
2026
Q1 		$24.4K Sell
840
-10
-1% -$291 ﹤0.01% 2677
2025
Q4 		$24.1K Sell
850
-400
-32% -$10.9K ﹤0.01% 2417
2025
Q3 		$30.4K Sell
1,250
-790
-39% -$18.2K ﹤0.01% 2205
2025
Q2 		$43.1K Sell
2,040
-50
-2% -$1.03K ﹤0.01% 1947
2025
Q1 		$44.3K Sell
2,090
-300
-13% -$6.67K ﹤0.01% 1808
2024
Q4 		$51.4K Buy
+2,390
New +$55.1K ﹤0.01% 1753

Other funds holding IBBQ

Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $77.5M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $762M AUM 59.13% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return
CFA
Churchill Financial Advisors Louisville, Kentucky $519M AUM
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

MAI Capital Management's IBBQ Position: Q2 2026 in Review

MAI Capital Management sold out of Invesco NASDAQ Biotechnology ETF (IBBQ) in Q2 2026, closing a stake of 840 shares — an estimated $24.4K sold.

MAI Capital Management first reported a position in IBBQ in Q4 2024 and held it in 6 quarters. The position peaked at $51.4K in Q4 2024. 35 funds tracked by Wall St. Rank hold IBBQ as of Q2 2026.

  • MAI Capital Management reported no remaining Invesco NASDAQ Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 840 Invesco NASDAQ Biotechnology ETF shares in Q2 2026, an estimated $24.4K.
  • MAI Capital Management first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Invesco NASDAQ Biotechnology ETF position peaked at $51.4K in Q4 2024.
  • 35 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.